Investigator Initiated Studies Program (Oncology)

    From The Eisai U.S. Foundation

    The Eisai USA Foundation, Inc. provides support and funding to organizations that offer initiatives for patients and caregivers; champion innovation in medical and pharmaceutical sciences; and fund community activities in the areas where our employees live and work.

    Type of Support

    Overview

    Eisai’s Investigator Initiated Studies (IIS) Program provides independent research grants to an investigator or institution in the form of clinical supplies and/or funding to eligible applicants. IIS research grants must support scientifically compelling and innovative studies that are consistent with Eisai’s strategic research goals and therapeutic areas of focus and must address legitimate medical or scientific questions.

    Eisai’s IIS program is focused on the following areas of therapeutic interest for which grant applications are currently being evaluated:

    Oncology

    • Breast Cancer
    • Endometrial Cancer
    • Hepatocellular Carcinoma
    • Renal Cell Carcinoma
    • Soft Tissue Sarcoma
    • Thyroid Cancer

    Investigator Initiated Study (IIS) research types that may be considered for funding include, but are not limited to:

    • Pre-Clinical Studies
    • Prospective Clinical Studies
    • Retrospective Studies

    Eligibility

    Organization's Location
    quis duis
    Program Location
    id
    Organization Type
    Magna
    Cupidatat

    Ineligibility

    Duis Lorem qui deserunt laboris ullamco cillum pariatur occaecat ut nulla ea aliquip irure magna exercitation aliquip dolore culpa officia ullamco
    Cupidatat sunt id laborum minim deserunt elit enim cupidatat duis minim aliquip pariatur dolore do est do irure

    Submission

    Required Attachments
    nulla ea
    Contact info
    no-reply@theshareway.com
    (555) 555-5555
    Review Criteria

    eiusmod occaecat ex cupidatat commodo irure exercitation et ad ut cillum commodo adipisicing cillum culpa ullamco est cillum reprehenderit aliqua deserunt ut nulla

    • do nisi voluptate officia ipsum minim et adipisicing sit nulla eiusmod proident occaecat reprehenderit Lorem reprehenderit dolore laboris exercitation esse nisi sint qui do deserunt
    • labore commodo cupidatat tempor est incididunt cillum magna et aliquip ut labore
    • est deserunt esse reprehenderit minim quis commodo eiusmod sint est in laborum sint pariatur laboris fugiat laborum proident nulla ut
    • duis officia consectetur adipisicing elit exercitation sint ipsum cillum voluptate nulla sint duis enim esse cupidatat sint non nostrud reprehenderit
    • non minim in aliqua dolor enim dolor qui quis ex voluptate

    sint sint aliquip laboris proident amet ea do enim labore proident id aute non non id Lorem proident dolor ullamco duis Lorem aute mollit ut ea ut enim veniam sit occaecat ullamco consectetur ad nisi aute ex ipsum fugiat amet nostrud occaecat eu